Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI)

CAPS Rating: 1 out of 5

The Company is engaged in developing, implementing and licensing scientific technology for the curing of tobacco and also manufactures, markets and develops very low-nitrosamine smokeless tobacco products and selling of discount cigarettes.


Player Avatar pchop123 (79.58) Submitted: 1/4/2013 10:19:18 AM : Underperform Start Price: $2.88 RCPI Score: +13.39

Double Dog Loser

Featured Broker Partners